Qiuwei Pan

Group Leader/Associate Professor

Erasmus MC

Netherlands

Research Interests

Explore related searches

Professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (17)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (14)

Markus Schlaich

University of Western Australia

AUSTRALIA

View details

Pengfei Li

Erasmus University Medical Center

NETHERLANDS

View details

Monique Verstegen

Erasmus University Rotterdam

NETHERLANDS

View details

Joost Boeckmans

Vrije Universiteit Brussel

BELGIUM

View details

Thomas Karlas

University Hospital Leipzig

GERMANY

View details

Nguan Soon Tan

Associate Professor

Nanyang Technological University (NTU)

SINGAPORE

View details

Hayato Nakagawa

JAPAN

View details

Denis E Kainov

Norwegian University of Science and Technology (NTNU)

NORWAY

View details

Jinwen Chen

Flinders University

AUSTRALIA

View details

Giulia Giordano

Associate Professor

University of Trento

ITALY

View details

Dr. med. Omar Thaher

Ruhr-Universität Bochum

GERMANY

View details

Professor Laith Alrubaiy

Swansea University

UNITED KINGDOM

View details

Stefano Romeo

SWEDEN

View details

Javier Crespo

Profesor Titular

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Qiuwei Pan

Research Interests

Explore related searches

Contact this professor

Articles (17)

A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease.

Drug repurposing screen identifies vidofludimus calcium and pyrazofurin as novel chemical entities for the development of hepatitis E interventions

Impact of chronic hepatitis B and concurrent steatosis on the risk of hepatocellular carcinoma

Planning for the optimal vaccination sequence in the context of a population-stratified model

Porcine-derived pancreatic enzyme replacement therapy linking to chronic hepatitis E: Broad implications

The distinct spatiotemporal evolutionary landscape of HBV and HDV largely determines the unique epidemic features of HDV globally

Mitochondrial quality control: prime targets for antiviral therapy?

Combating pan-coronavirus infection by indomethacin through simultaneously inhibiting viral replication and inflammatory response

Clinical Features, Antiviral Treatment, and Patient Outcomes: A Systematic Review and Comparative Analysis of the Previous and the 2022 Mpox Outbreaks

Seasonal coronavirus infections trigger NLRP3 inflammasome activation in macrophages but is therapeutically targetable

Hepatitis E virus infection remodels the mature tRNAome in macrophages to orchestrate NLRP3 inflammasome response

Immunosuppressants exert differential effects on pan‐coronavirus infection and distinct combinatory antiviral activity with molnupiravir and nirmatrelvir

Disparities in transmission dynamics of the 2022 mpox outbreaks between Europe and Americas

Probability of Mpox importation during the FIFA World Cup 2022 in Qatar

A Novel Viral Infection Model to Guide Optimal Mpox Treatment

Cancer-associated fibroblasts nurture LGR5 marked liver tumor-initiating cells and promote their tumor formation, growth, and metastasis

Projecting the impact of testing and vaccination on the transmission dynamics of the 2022 monkeypox outbreak in the USA

Collaborators (14)

Markus Schlaich

Pengfei Li

Monique Verstegen

Joost Boeckmans

Thomas Karlas

Nguan Soon Tan

Hayato Nakagawa

Denis E Kainov

Jinwen Chen

Giulia Giordano

Dr. med. Omar Thaher

Professor Laith Alrubaiy

Stefano Romeo

Javier Crespo

Make your next move.